871814005: Product containing sacituzumab govitecan in parenteral dose form (medicinal product form)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Topoisomerase inhibitor-containing product\Sacituzumab govitecan-containing product\Sacituzumab govitecan-containing product in parenteral dose form
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Antibody-containing product\Monoclonal antibody-containing product\Monoclonal antibody antineoplastic agent\Sacituzumab govitecan-containing product\Sacituzumab govitecan-containing product in parenteral dose form
• \Medicinal product categorised by therapeutic role\Antineoplastic agent\Monoclonal antibody antineoplastic agent\Sacituzumab govitecan-containing product\Sacituzumab govitecan-containing product in parenteral dose form
• \Product manufactured as parenteral dose form\Sacituzumab govitecan-containing product in parenteral dose form

Status: current, Defined. Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
3974735012	Product containing sacituzumab govitecan in parenteral dose form (medicinal product form)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
3974736013	Sacituzumab govitecan-containing product in parenteral dose form	en	Synonym	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start